Junayd Hussain , Rabeeyah Ahmed , Cal H. Robinson , Nivethika Jeyakumar , Graham Smith , Tammy M. Brady , Allison B. Dart , Janis Dionne , Sabine Karam , Ashlene McKay , Rulan S. Parekh , Manish D. Sinha , Andrew M. South , Carol Vincent , Rahul Chanchlani
{"title":"Healthcare resource utilisation and costs associated with hypertension in children and adolescents: a population-based cohort study","authors":"Junayd Hussain , Rabeeyah Ahmed , Cal H. Robinson , Nivethika Jeyakumar , Graham Smith , Tammy M. Brady , Allison B. Dart , Janis Dionne , Sabine Karam , Ashlene McKay , Rulan S. Parekh , Manish D. Sinha , Andrew M. South , Carol Vincent , Rahul Chanchlani","doi":"10.1016/j.lana.2025.101157","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The global prevalence of paediatric hypertension has increased, contributing to long-term cardiovascular and kidney morbidity. However, healthcare resource utilisation and costs attributable to paediatric hypertension remain uncertain. This study evaluates healthcare utilisation and costs among hypertensive children compared to controls.</div></div><div><h3>Methods</h3><div>In a population-based retrospective cohort study, we analysed youth (aged 3–18 years) diagnosed with hypertension in Ontario, Canada (1993–2021). Using propensity score matching, 25,605 hypertensive children were compared to 128,025 controls and followed until death, emigration, or 31 March 2022. Healthcare utilisation (hospitalisations, emergency visits, outpatient visits) was assessed via negative binomial regression. Secondary outcomes included healthcare costs and specialist follow-up.</div></div><div><h3>Findings</h3><div>Median age was 15 years [IQR 11–17], 49% were female, and comorbidities were uncommon (4% (6497/153,630) congenital heart disease, 2% (9359/153,630) malignancy, 2% (2892/153,630) diabetes, 1% (2004/153,630) chronic kidney disease). Over a median follow-up of 12.9 [IQR 6.8–19.9] years, hypertensive children had higher hospitalisations (rate ratio [RR] 2.13, 95% CI 2.03–2.22), emergency visits (RR 1.08, 95% CI 1.05–1.11), and outpatient visits (RR 1.33, 95% CI 1.31–1.34). Mean healthcare costs were substantially higher in children with hypertension, especially in the first year ($16,690 vs $2659 per person-year).</div></div><div><h3>Interpretation</h3><div>Healthcare resource utilisation was significantly higher in youth with hypertension. These findings provide a basis for future cost-effectiveness studies on preventing paediatric hypertension and its complications.</div></div><div><h3>Funding</h3><div>This study was funded in part by a 2021/2022 <span>CoRE Builder Team</span> Grant from <span>McMaster University’s</span> Department of Paediatrics and supported by <span>ICES Western</span>, funded by the <span>Ontario Ministry of Health</span> (MOH) and <span>Ministry of Long-Term Care</span>.</div></div>","PeriodicalId":29783,"journal":{"name":"Lancet Regional Health-Americas","volume":"48 ","pages":"Article 101157"},"PeriodicalIF":7.0000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Regional Health-Americas","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667193X2500167X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The global prevalence of paediatric hypertension has increased, contributing to long-term cardiovascular and kidney morbidity. However, healthcare resource utilisation and costs attributable to paediatric hypertension remain uncertain. This study evaluates healthcare utilisation and costs among hypertensive children compared to controls.
Methods
In a population-based retrospective cohort study, we analysed youth (aged 3–18 years) diagnosed with hypertension in Ontario, Canada (1993–2021). Using propensity score matching, 25,605 hypertensive children were compared to 128,025 controls and followed until death, emigration, or 31 March 2022. Healthcare utilisation (hospitalisations, emergency visits, outpatient visits) was assessed via negative binomial regression. Secondary outcomes included healthcare costs and specialist follow-up.
Findings
Median age was 15 years [IQR 11–17], 49% were female, and comorbidities were uncommon (4% (6497/153,630) congenital heart disease, 2% (9359/153,630) malignancy, 2% (2892/153,630) diabetes, 1% (2004/153,630) chronic kidney disease). Over a median follow-up of 12.9 [IQR 6.8–19.9] years, hypertensive children had higher hospitalisations (rate ratio [RR] 2.13, 95% CI 2.03–2.22), emergency visits (RR 1.08, 95% CI 1.05–1.11), and outpatient visits (RR 1.33, 95% CI 1.31–1.34). Mean healthcare costs were substantially higher in children with hypertension, especially in the first year ($16,690 vs $2659 per person-year).
Interpretation
Healthcare resource utilisation was significantly higher in youth with hypertension. These findings provide a basis for future cost-effectiveness studies on preventing paediatric hypertension and its complications.
Funding
This study was funded in part by a 2021/2022 CoRE Builder Team Grant from McMaster University’s Department of Paediatrics and supported by ICES Western, funded by the Ontario Ministry of Health (MOH) and Ministry of Long-Term Care.
期刊介绍:
The Lancet Regional Health – Americas, an open-access journal, contributes to The Lancet's global initiative by focusing on health-care quality and access in the Americas. It aims to advance clinical practice and health policy in the region, promoting better health outcomes. The journal publishes high-quality original research advocating change or shedding light on clinical practice and health policy. It welcomes submissions on various regional health topics, including infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, emergency care, health policy, and health equity.